跳至主要内容
临床试验/NCT07032194
NCT07032194招募中不适用

Use of the Da Vinci Single Port Robotic System in Urological Surgery: A Prospective Observational Study (SP-URO)

Fondazione del Piemonte per l'Oncologia1 个研究点 分布在 1 个国家目标入组 250 人开始时间: 2025年2月19日最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
250
试验地点
1
主要终点
Perioperative complication rate

研究概览

简要总结

A prospective observational study aimed at evaluating the feasibility, safety, and effectiveness of the Da Vinci SP robotic system for urologic procedures at IRCCS Candiolo. The study collects perioperative, oncologic, and functional outcomes, with exploratory comparisons to the multiport Da Vinci Xi system.

详细描述

Minimally invasive surgery has significantly evolved with the introduction of robotic systems. The Da Vinci Single Port (SP) system, FDA-approved in 2018, allows procedures to be performed through a single incision. This single-center, prospective observational study conducted at IRCCS Candiolo aims to assess the safety, feasibility, and perioperative, oncologic, and functional outcomes of urologic procedures performed with the Da Vinci SP system.

Patients will be followed for up to 60 months post-surgery, with exploratory analysis comparing outcomes to those from procedures performed with the Da Vinci Xi (multiport) system. Data will include perioperative variables, complications, renal function, urinary continence, sexual potency, and oncologic parameters. Statistical analyses will be performed using Stata.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Signed informed consent and data privacy consent
  • Clinical indication for urologic robotic surgery per EAU guidelines or clinical trial eligibility
  • ECOG Performance Status 0-1
  • Life expectancy ≥ 10 years
  • Availability of preoperative clinical data
  • Willingness to comply with follow-up visits and data collection
  • Eligibility for robotic surgery

排除标准

  • Unsuitability for anesthesia
  • Cognitive or psychiatric disorders affecting consent or compliance

结局指标

主要结局

Perioperative complication rate

时间窗: Within 30 days post-surgery

The complication rate will be evaluated using the Clavien-Dindo classification, tracking complications during the perioperative period (30 days after surgery).

Conversion rate of SP robotic surgery

时间窗: Surgery through 30 postoperative days

Feasibility of performing urologic surgeries using the Da Vinci SP system will be evaluated in terms of conversion rate to multiport surgeries or open approach

次要结局

  • Surgical margins(Up to 60 months)
  • BCR(Up to 60 months)
  • CSM(Up to 60 months)
  • OM(Up to 60 months)
  • Continence recovery(3 to 60 months post-surgery)
  • Potency(3 to 60 months post-surgery)
  • Renal Function(3 to 60 months post-surgery)
  • Exploratory Endpoints (Comparison to Da Vinci Xi System)(End-of-study analysis (60 months))

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验